Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HARMONY-SMA combined therapy with Risdiplam and HAL-based robotic rehabilitation
jRCTs031240475Recruiting
- Sponsor
- Chugai Pharmaceutical Co., Ltd.
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of risdiplam in spinal muscular atrophy (SMA), sponsored by Chugai Pharmaceutical Co., Ltd. Started Nov 2024; status: recruiting.
02
Drugs
risdiplam
03
Conditions
spinal muscular atrophy (SMA)
Beyond the preview
Go deeper on jRCTs031240475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031240475.